SMEY

SMEY operates at the intersection of biotechnology and ingredient manufacturing, focusing on the production of sustainable alternatives to traditionally sourced materials for the food, cosmetics, and pharmaceutical industries. The company leverages biotechnology to create cultivated oils and butters, addressing supply chain and environmental concerns associated with tropical and resource-intensive ingredients.

Its product portfolio includes cCBE, a cultivated cocoa butter equivalent designed for use in chocolate, confectionery, and skincare, offering a cost-effective and low-impact substitute. Another key product is cHOB, a cultivated high-oleic butter positioned for the premium skincare, sunscreen, and makeup markets due to its stable, non-greasy properties and hydrating performance. The company also develops oil mixtures with fatty acid profiles similar to avocado oil, suitable for culinary applications requiring a high smoke point.

SMEY's business model appears to be B2B, supplying these cultivated ingredients to manufacturers in its target sectors. Revenue is generated through the sale of these proprietary biotech-derived products, which are positioned as solutions to enhance product performance, sustainability, and cost-efficiency for its clients.

Keywords: biotechnology, cultivated ingredients, cocoa butter alternative, specialty oils, sustainable materials, food ingredients, cosmetic ingredients, oleic butter, fatty acids, B2B supply